IART
Integra LifeSciences Surmounts Disruption with Resilient Q3 Performance
Integra LifeSciences, a leading medical technology company, recently reported its financial results for the third quarter of 2026. Despite facing challenges related to the Cincinnati flooding event and mixed performance across its portfolio, the company demonstrated resilience in its quarterly performance. The company delivered revenue of $411 million, which fell